<DOC>
	<DOCNO>NCT01968460</DOCNO>
	<brief_summary>This study evaluate oral fixed-dose , daily product combine pramipexole rasagiline treatment early Parkinson 's disease . Animal study support therapeutic advantage combine low dos rasagiline pramipexole suggest improvement administer sustained fashion . Both rasagiline pramipexole well know market drug Parkinson 's disease good safety profile . combine drug low dos control release may provide good symptom management exist drug alone together .</brief_summary>
	<brief_title>Safety , Tolerability Efficacy Two Doses Once Daily P2B001 Subjects With Early Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Rasagiline</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Subject male female ≥35 year age ≤75 year age time enrollment . Subject idiopathic Parkinson 's disease consistent UK Brain Bank Criteria ; must bradykinesia sequence effect rest tremor prominent motor asymmetry . Subject disease duration longer 3 year 0 month . Subject Hoehn &amp; Yahr ( H &amp; Y ) stage score &lt; 3 . Subject MMSE score ≥ 26 Subject atypical parkinsonian syndrome secondary parkinsonism ( e.g. , due drug , metabolic neurogenetic disorder , encephalitis , cerebrovascular disease degenerative disease ) . Subject history psychosis hallucination within previous 12 month . Subject take anticholinergic drug . Subject previous exposure levodopa dopamine agonist longer 4 week ; previous exposure le 4 week must within 2 month prior baseline visit . Subject previous exposure MAOB inhibitor longer 4 week ; previous exposure le 4 week must within 3 month prior baseline visit . Subject take MAO inhibitor , potent CYP1A2 inhibitor , e , g , Ciprofloxacin , Dextromethorphan antitussive agent , analgesic agent tramadol , meperidine , methadone propoxyphene , strong 3A4 inducer , e.g. , St. John 's Wort cyclobenzaprine ( tricyclic muscle relaxant ) , dopamine antagonist , neuroleptic ( phenothiazine , butyrophenones , thioxanthenes ) metoclopramide . Probenecid , cimetidine , ranitidine , diltiazem , verapamil quinidine .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Parkinson 's Disease , Rasagiline , Pramipexole</keyword>
</DOC>